{"id":8980,"date":"2022-04-08T17:00:00","date_gmt":"2022-04-08T15:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/"},"modified":"2022-04-08T17:00:00","modified_gmt":"2022-04-08T15:00:00","slug":"irlab-publicerar-sin-arsredovisning-for-2021","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/","title":{"rendered":"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021"},"content":{"rendered":"<p>[mfn_before_post]<\/p>\n<div class=\"mfn-preamble\">\n<p><strong>IRLAB (Nasdaq Stockholm: IRLAB A) meddelar idag att \u00e5rsredovisningen f\u00f6r 2021 finns tillg\u00e4nglig p\u00e5 f\u00f6retagets webbplats www.irlab.se.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Irlab\u00a0har idag publicerat \u00e5rsredovisning 2021 f\u00f6r r\u00e4kenskaps\u00e5ret 1 januari till 31 december 2021.\u00a0\u00c5rsredovisningen finns tillg\u00e4nglig p\u00e5 bolagets hemsida:\u00a0<a href=\"https:\/\/irlab.se\/sv\/investerare\/financial-reports\/\" target=\"_blank\" rel=\"nofollow noopener\">Finansiella rapporter &#8211; IRLAB<\/a>. En tryckt version av \u00e5rsredovisningen 2021 kommer finnas tillg\u00e4nglig fr\u00e5n och med slutet\u00a0av april.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information<\/strong><\/p>\n<hr\/>\n<p>Nicholas Waters, VD<br \/>Tel: +46 730 75 77 01<br \/>E-post:\u00a0<a href=\"mailto:nicholas.waters@irlab.se\" target=\"_blank\" rel=\"nofollow noopener\">nicholas.waters@irlab.se<\/a><\/p>\n<p>Viktor Siewertz, CFO<br \/>Tel: +46 727 10 70 70<br \/>E-post:\u00a0<a href=\"mailto:viktor.siewertz@irlab.se\" target=\"_blank\" rel=\"nofollow noopener\">viktor.siewertz@irlab.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-regulatory mfn-regulatory-vpml\">\n<p><em>Denna information \u00e4r s\u00e5dan information som IRLAB Therapeutics \u00e4r skyldigt att offentligg\u00f6ra enligt lagen om v\u00e4rdepappersmarknaden. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 2022-04-08 17:00 CEST.<\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong class=\"mfn-heading-1\">Om IRLAB<\/strong><\/p>\n<hr\/>\n<p>IRLAB uppt\u00e4cker och utvecklar nya l\u00e4kemedel f\u00f6r behandling av Parkinsons sjukdom och andra sjukdomar i hj\u00e4rnan. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och pirepemat (IRL752) \u00e4r b\u00e5da i Fas IIb och \u00e4r designade f\u00f6r att behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinsons sjukdom. Under 2021 ingick IRLAB ett exklusivt och globalt licensavtal med Ipsen f\u00f6r utveckling och marknadsf\u00f6ring av mesdopetam.<br \/>\u00a0<br \/>Genom den egenutvecklade forskningsplattformen ISP (Integrative Screening Process) har IRLAB uppt\u00e4ckt och utvecklat alla sina projekt och forts\u00e4tter att uppt\u00e4cka innovativa l\u00e4kemedelskandidater f\u00f6r behandling av sjukdomar relaterade till det centrala nervsystemet. F\u00f6rutom IRLAB:s starka kliniska pipeline driver IRLAB ett flertal prekliniska program d\u00e4r IRL942 och IRL757 \u00e4r i utveckling f\u00f6r Fas I. IRLAB \u00e4r noterat p\u00e5 Nasdaq Stockholms huvudlista. Mer information p\u00e5\u00a0<a href=\"http:\/\/www.irlab.se.\/\" target=\"_blank\" rel=\"nofollow noopener\">www.irlab.se.<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/storage.mfn.se\/7226660b-b871-4c09-807e-9e3bc4991079\/irlab-arsredovisning-2021.pdf\" class=\"mfn-primary\" target=\"_blank\" rel=\"nofollow noopener\">IRLAB \u00c5rsredovisning 2021<\/a><br \/><a href=\"https:\/\/storage.mfn.se\/6244699c-1d73-497a-a488-b532f5ac765c\/549300jat34lhei0dh60-2021-12-31-sv.zip\" target=\"_blank\" rel=\"nofollow noopener\">549300JAT34LHEI0DH60 2021 12 31 Sv<\/a><\/p>\n<\/div>\n<p>[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB (Nasdaq Stockholm: IRLAB A) meddelar idag att \u00e5rsredovisningen f\u00f6r 2021 finns tillg\u00e4nglig p\u00e5 f\u00f6retagets webbplats www.irlab.se.<\/p>\n","protected":false},"template":"","class_list":["post-8980","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-report-annual_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-report_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv","mfn-news-tag-mfn-regulatory-vpml_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB (Nasdaq Stockholm: IRLAB A) meddelar idag att \u00e5rsredovisningen f\u00f6r 2021 finns tillg\u00e4nglig p\u00e5 f\u00f6retagets webbplats www.irlab.se.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/\",\"name\":\"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2022-04-08T15:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021 - IRLAB","og_description":"IRLAB (Nasdaq Stockholm: IRLAB A) meddelar idag att \u00e5rsredovisningen f\u00f6r 2021 finns tillg\u00e4nglig p\u00e5 f\u00f6retagets webbplats www.irlab.se.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/","name":"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2022-04-08T15:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-publicerar-sin-arsredovisning-for-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB publicerar sin \u00e5rsredovisning f\u00f6r 2021"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/8980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=8980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}